In vitro activities of 2,2′-bipyridyl analogues against Mycobacterium avium and M. tuberculosis
- 1 April 1995
- journal article
- research article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 76 (2) , 136-140
- https://doi.org/10.1016/0962-8479(95)90556-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The global tuberculosis situation and the new control strategy of the World Health OrganizationPublished by Elsevier ,2004
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- Clinical aspects of mycobacterial infections in HIV infectionResearch in Microbiology, 1992
- Synthesis and copper-dependent antimycoplasmal activity of amides and amidines derived from 2-amino-1,10-phenanthrolineJournal of Medicinal Chemistry, 1991
- Isolation ofMycobacterium tuberculosisandM. aviumComplex from the Same Skin Lesions in AIDSNew England Journal of Medicine, 1990
- Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 2. AmidinesJournal of Medicinal Chemistry, 1989
- MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugsAntimicrobial Agents and Chemotherapy, 1988
- Synthesis and copper-dependent antimycoplasmal activity of 1-amino-3-(2-pyridyl)isoquinoline derivatives. 1. AmidesJournal of Medicinal Chemistry, 1988
- Determination of ansamycin MICs for Mycobacterium avium complex in liquid medium by radiometric and conventional methodsAntimicrobial Agents and Chemotherapy, 1985
- Comparative in vitro activities of MDL 473, rifampin, and ansamycin against Mycobacterium intracellulareAntimicrobial Agents and Chemotherapy, 1985